Zobrazeno 1 - 10
of 1 964
pro vyhledávání: '"A P, Bye"'
Autor:
Sakamoto-Rablah, Emily, Bye, Jordan, Modak, Arghya, Hooker, Andrew, Uddin, Shahid, McManus, Jennifer J
Protein engineering enables the creation of tailor-made proteins for an array of applications. ImmTACs stand out as promising therapeutics for cancer and other treatments, while also presenting unique challenges for stability, formulation and deliver
Externí odkaz:
http://arxiv.org/abs/2406.16610
Autor:
Monsalve, Raul A., Bye, Christian H., Sievers, Jonathan L., Bidula, Vadym, Bustos, Ricardo, Chiang, H. Cynthia, Guo, Xinze, Hendricksen, Ian, McGee, Francis, Mena, F. Patricio, Prabhakar, Garima, Restrepo, Oscar, Thyagarajan, Nithyanandan
Publikováno v:
2024, ApJ, 961, 56
The Mapper of the IGM Spin Temperature (MIST) is a new ground-based, single-antenna, radio experiment attempting to detect the global 21 cm signal from the Dark Ages and Cosmic Dawn. A significant challenge in this measurement is the frequency-depend
Externí odkaz:
http://arxiv.org/abs/2310.07741
Autor:
Monsalve, R. A., Altamirano, C., Bidula, V., Bustos, R., Bye, C. H., Chiang, H. C., Diaz, M., Fernandez, B., Guo, X., Hendricksen, I., Hornecker, E., Lucero, F., Mani, H., McGee, F., Mena, F. P., Pessoa, M., Prabhakar, G., Restrepo, O., Sievers, J. L., Thyagarajan, N.
Publikováno v:
Monthly Notices of the Royal Astronomical Society, Volume 530, Issue 4, June 2024, Pages 4125-4147
The observation of the global 21 cm signal produced by neutral hydrogen gas in the intergalactic medium (IGM) during the Dark Ages, Cosmic Dawn, and Epoch of Reionization requires measurements with extremely well-calibrated wideband radiometers. We d
Externí odkaz:
http://arxiv.org/abs/2309.02996
Autor:
Ingeborg Rossow, Elin K. Bye
Publikováno v:
BMC Public Health, Vol 24, Iss 1, Pp 1-8 (2024)
Abstract Background The alcohol harm paradox (APH) posits that alcohol harms are more prevalent in low socioeconomic position (SEP) groups compared to high SEP groups, when adjusted for alcohol consumption volume. Aim We explored whether APH is valid
Externí odkaz:
https://doaj.org/article/1a668b1fe2ae463eaea247f9064d2ce2
Publikováno v:
Scandinavian Journal of Primary Health Care, Vol 42, Iss 4, Pp 633-642 (2024)
Background Hospital at home (HaH) is an innovative approach to healthcare delivery that brings specialized services to patients’ homes. HaH services are typically available in urban areas where hospitals can easily reach nearby patients. An integra
Externí odkaz:
https://doaj.org/article/1de75e8c44774d99a80725fae2192b34
Autor:
Stephen Parkinson, Luigi Ceccaroni, Dori Edelist, Emily Robertson, Roxana Horincar, Claire Laudy, Todor Ganchev, Valentina Markova, Jay Pearlman, Pauline Simpson, Valentijn Venus, Patience Muchada, Garabet Kazanjian, Bente Lilja Bye, Marco Oliveira, Hugo Paredes, James Sprinks, Anna Witter, Bianca Cruz, Kaushiki Das, Sasha Marie Woods
Publikováno v:
ARPHA Proceedings, Vol 6, Iss , Pp 61-65 (2024)
In recent years, there has been growing interest in digital twins (or virtual representations) of the environment. Programs in the European Union and the UN are investing in digital twins, particularly those of the ocean (DTOs). While citizen science
Externí odkaz:
https://doaj.org/article/99a07a5db8f34b0499a13a6e67f0b909
Autor:
Lisa Heide Koteng, Kari Sand, Ingvild Paur, Asta Bye, Bente Ervik, Tora S. Solheim, Inger Ottestad, Trude R. Balstad
Publikováno v:
Clinical Nutrition Open Science, Vol 58, Iss , Pp 289-301 (2024)
Summary: Background and aim: Patients with cancer are at high risk of malnutrition, yet relevant ICD-10 codes for malnutrition are underutilized in cancer clinics. Understanding oncologists' perspectives is crucial for optimizing malnutrition diagnos
Externí odkaz:
https://doaj.org/article/9fbe746d9fc8413cb0ac0d0e75de877d
Autor:
Marit Slaaen, Inga Marie Røyset, Ingvild Saltvedt, Bjørn Henning Grønberg, Vidar Halsteinli, Øystein Døhl, Corinna Vossius, Øyvind Kirkevold, Sverre Bergh, Siri Rostoft, Line Oldervoll, Asta Bye, Line Melby, Tove Røsstad, Guro Falk Eriksen, May Ingvild Volungholen Sollid, Darryl Rolfson, Jūratė Šaltytė Benth
Publikováno v:
BMC Medicine, Vol 22, Iss 1, Pp 1-19 (2024)
Abstract Background Geriatric assessment and management (GAM) improve outcomes in older patients with cancer treated with surgery or chemotherapy. It is unclear whether GAM may provide better function and quality of life (QoL), or be cost-effective,
Externí odkaz:
https://doaj.org/article/1379215f5e7b480ebc8134a43826d473
Autor:
Marianne J. Hjermstad, Gunnhild Jakobsen, Jann Arends, Trude R. Balstad, Leo R. Brown, Asta Bye, Andrew J.S. Coats, Olav F. Dajani, Ross D. Dolan, Marie T. Fallon, Christine Greil, Alexandra Grzyb, Stein Kaasa, Lisa H. Koteng, Anne M. May, James McDonald, Inger Ottestad, Iain Philips, Eric J. Roeland, Judith Sayers, Melanie R. Simpson, Richard J.E. Skipworth, Tora S. Solheim, Mariana S. Sousa, Ola M. Vagnildhaug, Barry J.A. Laird, the Cancer Cachexia Endpoints Working Group
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle, Vol 15, Iss 3, Pp 794-815 (2024)
Abstract The use of patient‐reported outcomes (PROMs) of quality of life (QOL) is common in cachexia trials. Patients' self‐report on health, functioning, wellbeing, and perceptions of care, represent important measures of efficacy. This review d
Externí odkaz:
https://doaj.org/article/7a15d61b7a0c4d80b36bc24f394b913a
Autor:
Michael S. Yule, Joshua Thompson, Khachonphat Leesahatsawat, Mariana S. Sousa, Stefan D. Anker, Jann Arends, Trude R. Balstad, Leo R. Brown, Asta Bye, Olav Dajani, Marie Fallon, Marianne J. Hjermstad, Gunnhild Jakobsen, James McDonald, Josh McGovern, Eric J. Roeland, Judith Sayers, Richard J.E. Skipworth, Inger O. Ottestad, Iain Philips, Melanie R. Simpson, Tora S. Solheim, Ola Magne Vagnildhaug, Donald McMillan, Barry J.A. Laird, Ross D. Dolan, the Cancer Cachexia Endpoints Working Group
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle, Vol 15, Iss 3, Pp 853-867 (2024)
Abstract Regulatory agencies require evidence that endpoints correlate with clinical benefit before they can be used to approve drugs. Biomarkers are often considered surrogate endpoints. In cancer cachexia trials, the measurement of biomarkers featu
Externí odkaz:
https://doaj.org/article/b91388b921c54b20be4595865bc85c5f